News

Vanda Pharmaceuticals Set to Share Q3 2025 Results October 29

Vanda Pharmaceuticals Set to Share Q3 2025 Results October 29

Vanda Pharmaceuticals to Reveal Third Quarter 2025 Results

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) has announced that its financial results for the third quarter of 2025 will be disclosed on a Wednesday, marking a significant moment for investors and stakeholders. The anticipated release will occur after market closure on October 29, 2025.

Details of the Conference Call

To facilitate thorough discussion about its performance and future plans, Vanda will host a conference call at 4:30 PM ET on the same day. During this call, management will provide insights into the financial results, highlighting key developments and ongoing corporate activities. 

Interested parties can join the conversation by dialing either 1-888-596-4144 for domestic participants or 1-646-968-2525 for those calling internationally. It's essential to use the designated passcode 8728050 to join the call smoothly.

Accessing the Live Broadcast

The conference call will also be available via live broadcast, which will subsequently be archived on Vanda's official website. Investors are encouraged to visit the website ahead of time to ensure they meet the technical requirements for participation.

Replay Availability

A recorded version of the conference call will be accessible shortly after its conclusion on October 29, 2025, beginning at 8:30 PM ET. The replay will remain available until November 5, 2025, at 11:59 PM ET. Domestic callers can access the replay by calling 1-800-770-2030 and international callers should dial 1-609-800-9909, using the same passcode for access.

About Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals is renowned as a pivotal player in the biopharmaceutical sector, specializing in the development and commercialization of advanced therapies designed to meet significant unmet medical needs. Its commitment to innovation remains at the core of its mission to enhance the quality of life for patients worldwide.

For further information, please visit Vanda Pharmaceuticals’ website and connect with the company through their social channels to stay updated on the latest news.

Corporate Contact Information

For any inquiries or more information, Vanda Pharmaceuticals has established clear communication channels. Kevin Moran serves as the Senior Vice President, Chief Financial Officer, and Treasurer at Vanda Pharmaceuticals Inc. He can be reached at 202-734-3400 for corporate inquiries.

The Team Behind Vanda Pharmaceuticals

The Vanda team also includes professionals from Collected Strategies, including Jim Golden, Jack Kelleher, and Dan Moore, who jointly contribute to the company's strategic efforts and communications.

Frequently Asked Questions

When will Vanda Pharmaceuticals announce its Q3 2025 results?

The announcement is scheduled for October 29, 2025, after the market closes.

How can I participate in the conference call?

You can participate by calling 1-888-596-4144 for domestic or 1-646-968-2525 for international access, using passcode 8728050.

Will the conference call be available for replay?

Yes, the replay will be available starting October 29, 2025, at 8:30 PM ET, until November 5, 2025.

What is Vanda Pharmaceuticals' main focus?

Vanda Pharmaceuticals focuses on developing innovative therapies that address significant unmet medical needs and improve patient lives.

Who can I contact for more information?

For inquiries, you may contact Kevin Moran at 202-734-3400.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Delta Dental Expands Free Oral Care Access in NM

Updated Category News Views 160

Bridging Dental Care Gaps in New Mexico When the calendar flips to early November, Delta Dental of New Mexico is joining hands with the NM Mission of Mercy for a no-cost dental clinic at EXPO New Mexico. We're talking doors flying open at 5:15 a.m. sharp, on November 6 and 7. This isn’t some run-of-the-mill thing—they are targeting those who can't easily get or afford...

Continue Reading
Muyuan Foods Spotlights Smart Farming at EuroTier 2026

Updated Category News Views 27

Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...

Continue Reading
NovoTech Climbs Charts: Chambers USA Spotlight Kudos

Updated Category News Views 125

NovoTech's Moment in the Spotlight Every once in a while, a small fish manages to swim with the sharks and come out shining. NovoTech, a relative newcomer in the swarm of patent law firms, has snagged itself a spot in the inaugural Chambers USA Spotlight 2027 DC Metro Guide. Considering they're playing in the bustling intellectual property scene, this is no small...

Continue Reading
Kestrel Group Faces Financial Hit Despite Revenue Growth

Updated Category News Views 122

Kestrel's Financial Rollercoaster Continues Here's the deal with Kestrel Group, folks. They just dropped their Q3 2026 financials, and it's a mixed bag. The top line's looking solid with total revenues hitting $4.8 million, riding high on a 203% jump in Program Services fee income. But dig a little deeper, and there's a $16.4 million net loss staring us in the face....

Continue Reading
Zillow Set for Major Talks at RBC Capital Markets Conference

Updated Category News Views 90

Zillow Group Prepares for a Key Presentation Turning heads again, Zillow Group, a heavyweight in real estate innovation, is gearing up for a spotlight moment. Come November 17, they're taking the stage at the RBC Capital Markets Global Technology, Internet, Media & Telecommunications Conference in the Big Apple. Now, these corporate shindigs aren't always a ticker...

Continue Reading
Deep Principle's Hydrogen-1.0: A Leap in AI-Driven Chemistry

Updated Category News Views 121

Leaving Old Lab Notebooks in the Dust Deep Principle just shook up the science lab with their latest brainchild, Hydrogen-1.0. We're talking about an AI-driven marvel designed to tackle chemistry and materials research like no traditional lab rat ever could. On November 4, they rolled out this bad boy—an open-weight model fine-tuned to turn vague scientific hunches into...

Continue Reading
Gildan Class Action: What Investors Should Know

Updated Category News Views 43

Playing Hardball: Gildan Faces Serious Claims Gildan Activewear Inc. (NYSE:GIL) isn't just dealing with wardrobe malfunctions; it's knee-deep in a class action lawsuit that's got investors on edge. The allegations? Accusations of deceptive practices like channel stuffing, which supposedly jazzed up their financials by moving unsold products through distribution channels...

Continue Reading
Brigham Nurses Set to Strike: MGB Board Faces Scrutiny

Updated Category News Views 50

Pressure Cooker: MGB in the Hot Seat Nurses from Brigham and Women's Hospital aren't backing down, folks. They're feverishly preparing for a full-scale strike, set to kick off on November 12, if Mass General Brigham (MGB) doesn't budge on contract negotiations. Since today is November 6, they've got just a few days to find common ground. Let me tell you, the stakes...

Continue Reading
CassTime's AI Solution Eases Global Parts Market Strains

Updated Category News Views 60

Driving Innovation in the Auto Aftermarket When car parts become a global jigsaw puzzle, you need more than wrenches to solve it. Enter CassTime with its AI-driven 'T+D Solution'—a tangible answer to the woes of data matching and repair capability bottlenecks plaguing the automotive aftermarket worldwide. Taming the Global Parts Beast Pull back the curtain on AAPEX 2026...

Continue Reading
Capitol Securities Adds Financial Veterans to Team

Updated Category News Views 116

Big Moves in Sarasota: Capitol Securities' New Additions In a world where every Wall Street whisper can send ripples through financial markets, Capitol Securities Management's move to bring on Joe Malave and Katy Carrigan is anything but a minor footnote. You'd think, by now, we'd be numb to industry shifts, but when a pro like Malave, with his 30 years of financial...

Continue Reading

Top 5 Most Recently Viewed Articles

Current Market Sentiment Surrounding Ameriprise Financial Inc.

Updated Category News Views 210

Current Overview of Ameriprise Financial Inc's Market Position Ameriprise Financial Inc's (NYSE: AMP) short interest has demonstrated significant changes recently. The short interest, or the percentage of shares sold short relative to total float, has decreased by 8.0% since the last report. Currently, there are 2.20 million shares sold short, representing 2.76% of the...

Continue Reading
Analyzing McKesson's Advantage in the Options Market Today

Updated Category News Views 132

Investors' Optimism Towards McKesson There's a palpable sense of bullish sentiment surrounding McKesson, a key player in the pharmaceutical wholesale industry. Known by its stock ticker MCK, the company has captured the attention of affluent investors who are making notable moves in the options market. It’s essential for retail traders to keep an eye on these...

Continue Reading
Tuya Inc. Delivers Impressive Q2 2025 Financial Results

Updated Category News Views 329

Tuya Inc. Reports Strong Financial Performance for Q2 2025 Tuya Inc. (NYSE: TUYA), a prominent AI-driven cloud platform service provider, has released its second-quarter financial results for the year, reflecting a firm commitment to innovation and robust market strategies. This latest report outlines a remarkable growth trajectory as the company adapts to shifting market...

Continue Reading
Understanding Winter's Toll on Your Pet's Health and Comfort

Updated Category News Views 151

How Winter Weather Affects Our Beloved Pets As the chill of winter descends, pet owners must consider the effects this season can have on their furry friends, particularly older pets. As we layer ourselves in cozy sweaters, our pets may struggle with discomfort and pain, especially in their joints. It’s essential to stay aware of these changes to ensure our pets remain...

Continue Reading
Celebrating Creative Achievements in Psychoanalysis: The Sigourney Award

Updated Category News Views 144

The Sigourney Award-2025 Recognizes Innovative Contributions The Sigourney Award-2025 has celebrated four outstanding recipients for their creative contributions that expand psychoanalytic thought on a global scale. This prestigious award is designed to recognize significant work that showcases the advancements and applications of psychoanalysis. The announcement was made...

Continue Reading